Abstract submissions are now closed.
MTIS 2022 has welcomed submissions of abstracts for original contribution to the field in the following topics listed below:
- Epidemiology, comorbidity, outcomes and classification, including big data
- General and organisational aspects of headache care
Telemedicine
E-tools - Genetics and biomarkers of headache disorders
- Headache Pathophysiology: Basic Research
- Headache Pathophysiology: Clinical Research
- Headache Pathophysiology: Imaging
- Migraine – acute therapy: Pharmacological and Device based
- Migraine – preventive therapy: Pharmacological and Device based
- Cluster headache and other TACs
- Tension-type headache and other primary headaches (in line with ICHD-3 terminology '4. other primary headache disorders')
- Medication overuse headache
- Post-traumatic headache, COVID-associated headache
- Idiopathic intracranial hypertension
- Other secondary headaches
- Paediatric headache
- Post-traumatic headache
- Psychological and behaviour factors
Important Dates
Submissions Accepted From
1 March 2022
Submission Deadline
1 June 2022, 12:00 Midday (BST)
Abstract Review
June 2022
Late Breaking Abstracts
There will be a chance to submit ‘late breaking’ abstracts from 4 July 2022 for two weeks – Details of this will follow in due course
Please click here to review the MTIS Abstract Guidelines.
